Latest Content

Survey Findings Reveal Financial Challenges in Patients with Cancer

April 3rd 2025, 9:00pm

By Ryan Scott

Article

Among patients with cancer, high out-of-pocket costs were found to impact access to health care, adherence to medication, as well as quality of life.

Breaking Down Kidney Cancer Treatment Advancements and Providing Hope

April 3rd 2025, 8:00pm

By Sid Salder

Video

Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

April 3rd 2025, 7:00pm

By Dr Lillian Siu

Article

April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.

How Breast Cancer Taught Me Resilience in Unexpected Life Challenges

April 3rd 2025, 5:00pm

By Natasha Carlson

Article

Lessons I learned from a cancer diagnosis have been applied in some surprising and seemingly unrelated aspects of my life.

NG-350A Evaluated in FORTRESS Trial for Locally Advanced Rectal Cancer

April 3rd 2025, 4:01pm

By Ryan Scott

Article

The first patient with locally advanced rectal cancer has been enrolled in the FORTRESS study which is evaluating the investigative immunotherapy NG-350A.

Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial

April 3rd 2025, 3:00pm

By Spencer Feldman

Article

Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for further treatment expansion.

Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted

April 3rd 2025, 1:00pm

By Alex Biese

Article

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on to final analysis.

FDA Approves Initiation of a New Trial in Recurrent Glioblastoma

April 2nd 2025, 9:00pm

By Ryan Scott

Article

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a form of brain cancer.

The Benefit of Clinical Trial Enrollment for Patients With Cancer

April 2nd 2025, 8:00pm

By Dr. Michael J. Pishvaian

Video

There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.

Addressing Gaps, Challenges and Disparities in AYA Cancer Care

April 2nd 2025, 7:00pm

By Ryan Scott

Article

Adolescent and young adult patients with cancer face delayed diagnoses, financial hardships and gaps in specialized care, creating a need for tailored support.

Unexpected Challenges 11 Years After Breast Cancer

April 2nd 2025, 5:20pm

By Bonnie Annis

Article

Eleven years post diagnosis and issues related to breast cancer still frustrate me.

Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial

April 2nd 2025, 4:35pm

By Spencer Feldman

Article

Camrelizumab combo doubled the five-year survival rate in advanced squamous lung cancer, reducing mortality risk by 43%, in a Phase 3 trial.

A New Comprehensive Hereditary Cancer Solution Has Been Launched

April 2nd 2025, 3:00pm

By Alex Biese

Article

A new comprehensive hereditary cancer solution offers genetic counseling and multigene panels to enhance early detection of disease's like brain cancer.

NeuroSAFE Increases Erectile Function After Prostate Cancer Surgery

April 2nd 2025, 1:00pm

By Dr. Greg Shaw

Video

Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.

What Role Does MRD Play in Multiple Myeloma Treatment Decision Making?

April 1st 2025, 9:00pm

By Alex Biese

Article

Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.